Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2002 Apr;75(3):302-4.
doi: 10.1007/BF02982046.

Reversible acceleration of disease progression following cyclosporin A treatment in a patient with myelodysplastic syndrome

Affiliations
Case Reports

Reversible acceleration of disease progression following cyclosporin A treatment in a patient with myelodysplastic syndrome

Mitsuru Itoh et al. Int J Hematol. 2002 Apr.

Abstract

A 38-year-old Japanese man with myelodysplastic syndrome (MDS), whose bone marrow smears demonstrated hypercellularity, was treated with oral cyclosporin A (CsA) therapy. During the course of this therapy, the numbers of peripheral blood and bone marrow blasts increased and the level of serum lactate dehydrogenase increased. After discontinuation of CsA treatment, all of these levels rapidly decreased. We consider that CsA might accelerate disease progression in certain MDS cases.

PubMed Disclaimer

References

    1. Cancer. 1988 Sep 1;62(5):958-64 - PubMed
    1. Br J Haematol. 1998 Feb;100(2):304-9 - PubMed
    1. Br J Haematol. 1997 Dec;99(3):699-705 - PubMed
    1. Am J Hematol. 1989 Nov;32(3):226-9 - PubMed
    1. Int J Hematol. 1999 Oct;70(3):141-54 - PubMed

Publication types